Chen-Fuh Lam

1.0k total citations
30 papers, 829 citations indexed

About

Chen-Fuh Lam is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chen-Fuh Lam has authored 30 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chen-Fuh Lam's work include Cardiac Ischemia and Reperfusion (7 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Nitric Oxide and Endothelin Effects (5 papers). Chen-Fuh Lam is often cited by papers focused on Cardiac Ischemia and Reperfusion (7 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Nitric Oxide and Endothelin Effects (5 papers). Chen-Fuh Lam collaborates with scholars based in Taiwan, United States and Australia. Chen-Fuh Lam's co-authors include Yu‐Chuan Tsai, Jun‐Neng Roan, Zvonimir S. Katušić, Yen‐Chin Liu, Livius V. d’Uscio, Anthony J. Croatt, Karl A. Nath, Timothy E. Peterson, Ming‐Wei Lin and Tongrong He and has published in prestigious journals such as PLoS ONE, Circulation Research and Scientific Reports.

In The Last Decade

Chen-Fuh Lam

30 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen-Fuh Lam Taiwan 17 238 204 202 151 138 30 829
Giovana Seno Di Marco Germany 19 465 2.0× 186 0.9× 146 0.7× 214 1.4× 146 1.1× 38 1.5k
Tien‐Hung Huang Taiwan 21 372 1.6× 242 1.2× 136 0.7× 124 0.8× 104 0.8× 37 996
Ken Yamaura Japan 17 177 0.7× 275 1.3× 107 0.5× 220 1.5× 137 1.0× 111 976
Masato Kimura Japan 20 165 0.7× 189 0.9× 168 0.8× 101 0.7× 162 1.2× 82 1.2k
Tiebing Zhu China 20 431 1.8× 246 1.2× 86 0.4× 212 1.4× 64 0.5× 47 1000
Robert Scheubel Germany 14 544 2.3× 216 1.1× 179 0.9× 309 2.0× 133 1.0× 29 1.1k
Jianteng Gu China 14 360 1.5× 199 1.0× 161 0.8× 116 0.8× 81 0.6× 43 1.3k
Radovan Vasko Germany 19 367 1.5× 151 0.7× 121 0.6× 65 0.4× 188 1.4× 41 1.3k
Tomasz Wietecha United States 18 389 1.6× 265 1.3× 79 0.4× 115 0.8× 207 1.5× 33 1.3k
Min‐Yu Lan Taiwan 19 369 1.6× 104 0.5× 171 0.8× 166 1.1× 106 0.8× 58 1.1k

Countries citing papers authored by Chen-Fuh Lam

Since Specialization
Citations

This map shows the geographic impact of Chen-Fuh Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen-Fuh Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen-Fuh Lam more than expected).

Fields of papers citing papers by Chen-Fuh Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen-Fuh Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen-Fuh Lam. The network helps show where Chen-Fuh Lam may publish in the future.

Co-authorship network of co-authors of Chen-Fuh Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Chen-Fuh Lam. A scholar is included among the top collaborators of Chen-Fuh Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen-Fuh Lam. Chen-Fuh Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Chih‐Hsin, et al.. (2020). Transplantation of viable mitochondria improves right ventricular performance and pulmonary artery remodeling in rats with pulmonary arterial hypertension. Journal of Thoracic and Cardiovascular Surgery. 163(5). e361–e373. 32 indexed citations
2.
Roan, Jun‐Neng, et al.. (2020). ProT-α gene transfer attenuates cardiopulmonary remedying and mortality in a flow-induced pulmonary hypertension rat model. The Journal of Heart and Lung Transplantation. 39(10). 1126–1135. 3 indexed citations
3.
Chen, Chun‐Lin, et al.. (2018). Morphine Induces Fibroblast Activation through Up-regulation of Connexin 43 Expression: Implication of Fibrosis in Wound Healing. International Journal of Medical Sciences. 15(9). 875–882. 8 indexed citations
4.
Hsu, Chih‐Hsin, et al.. (2017). Exendin-4 improves cardiovascular function and survival in flow-induced pulmonary hypertension. Journal of Thoracic and Cardiovascular Surgery. 155(4). 1661–1669.e4. 16 indexed citations
5.
Roan, Jun‐Neng, et al.. (2016). Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing. Journal of Surgical Research. 208. 93–103. 36 indexed citations
6.
Lin, Wei‐Hung, et al.. (2014). Incidence of and Mortality from Type I Diabetes in Taiwan From 1999 through 2010: A Nationwide Cohort Study. PLoS ONE. 9(1). e86172–e86172. 49 indexed citations
7.
Chen, Chung-Hao, et al.. (2014). Preconditioning renoprotective effect of isoflurane in a rat model of virtual renal transplant. Journal of Surgical Research. 189(1). 135–142. 7 indexed citations
8.
Roan, Jun‐Neng, et al.. (2014). Rosuvastatin Suppresses the Oxidative Response in the Venous Limb of an Arteriovenous Fistula and Enhances the Fistula Blood Flow in Diabetic Rats. Journal of Vascular Research. 51(2). 81–89. 14 indexed citations
9.
Roan, Jun‐Neng, et al.. (2013). Pleiotropic vascular protective effects of statins in perioperative medicine. Acta anaesthesiologica Taiwanica. 51(3). 120–126. 14 indexed citations
10.
Roan, Jun‐Neng, et al.. (2012). Cardiovascular Protection of Activating KATP Channel During Ischemia-Reperfusion Acidosis. Shock. 37(6). 653–658. 7 indexed citations
11.
Roan, Jun‐Neng, et al.. (2012). Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model. Journal of Vascular Surgery. 56(5). 1381–1389.e1. 25 indexed citations
12.
Li, Shengping, et al.. (2012). The preconditioning pulmonary protective effect of volatile isoflurane in acute lung injury is mediated by activation of endogenous iNOS. Journal of Anesthesia. 26(6). 822–828. 19 indexed citations
13.
Roan, Jun‐Neng, et al.. (2011). Functional Dilatation and Medial Remodeling of the Renal Artery in Response to Chronic Increased Blood Flow. Kidney & Blood Pressure Research. 34(6). 447–456. 5 indexed citations
15.
Lam, Chen-Fuh, et al.. (2010). Inhibition of ATP-sensitive potassium channels attenuates propofol-induced vasorelaxation. Critical Care and Resuscitation. 12(3). 186–190. 15 indexed citations
16.
Huang, Yu-Sheng, et al.. (2010). Morphine enhances tissue content of collagen and increases wound tensile strength. Journal of Anesthesia. 24(2). 240–246. 25 indexed citations
17.
Lam, Chen-Fuh, et al.. (2008). Prolonged Use of High-Dose Morphine Impairs Angiogenesis and Mobilization of Endothelial Progenitor Cells in Mice. Anesthesia & Analgesia. 107(2). 686–692. 57 indexed citations
18.
Lam, Chen-Fuh, et al.. (2007). High-dose Morphine Impairs Vascular Endothelial Function by Increased Production of Superoxide Anions. Anesthesiology. 106(3). 532–537. 37 indexed citations
19.
Lam, Chen-Fuh, Timothy E. Peterson, Darcy M. Richardson, et al.. (2005). Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin. American Journal of Physiology-Heart and Circulatory Physiology. 290(2). H786–H793. 73 indexed citations
20.
Heerden, Peter Vernon van, Sigal Sviri, Kenneth F. Ilett, & Chen-Fuh Lam. (2002). Inhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators. Expert Opinion on Investigational Drugs. 11(7). 897–909. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026